Viewing Study NCT03469804


Ignite Creation Date: 2025-12-24 @ 9:21 PM
Ignite Modification Date: 2025-12-25 @ 7:08 PM
Study NCT ID: NCT03469804
Status: UNKNOWN
Last Update Posted: 2019-10-21
First Post: 2018-03-12
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase II Multicentric Study of Pembrolizumab in Classic or Endemic Kaposi's Sarcoma
Sponsor: Assistance Publique - Hôpitaux de Paris
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module